Log in

6891 Locus Cell Co., Ltd. TPEX · Taiwan

Locus Cell Co. (6891) news

Locus Cell Co., Ltd. is a public biotech or pharmaceutical company listed on TPEX under the ticker 6891, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Locus Cell Co. news

We have not published a story on Locus Cell Co. yet. When there is news, it will appear here.

Questions about Locus Cell Co.

What is the ticker symbol of Locus Cell Co.?

Locus Cell Co., Ltd. trades under the ticker 6891 on TPEX.

Where is Locus Cell Co. listed?

Locus Cell Co., Ltd. is listed on TPEX.

Which country or territory is Locus Cell Co. listed under?

Our directory records Locus Cell Co., Ltd. under Taiwan.

What does Locus Cell Co. do?

Our directory classifies Locus Cell Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Locus Cell Co.?

The ISIN recorded for Locus Cell Co., Ltd. is TW0006891005.

Does aibio.space cover Locus Cell Co.?

aibio.space lists Locus Cell Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Locus Cell Co.?

Companies in our directory listed in the same country and business area as Locus Cell Co.: Pharmosa Biopharm, Shine-On Biomedical Co., Bioptic, Energenesis Biomedical Co., Steminent Biotherapeutics, HCmed Innovations Co..

Investor discussion: Locus Cell Co.

Members talk about Locus Cell Co. (6891). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TPEX:6891 on TradingView.

Listing details

Locus Cell Co., Ltd. is a public biotech or pharmaceutical company listed on TPEX under the ticker 6891, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Locus Cell Co., Ltd.
Ticker
6891
Listing
TPEX
Country or territory
Taiwan
Business scope
Biotechnology
ISIN
TW0006891005
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.